Earnings · China A-shares

Chengdu Olymvax Biopharmaceuticals Inc. Class A (688319) earnings

Chengdu Olymvax Biopharmaceuticals Inc. Class A published its Q3 report on 2026-10-29: net profit -114.33% year on year, -57.86% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +6.34% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-29
Period end
2026-09-30
Net profit YoY
-114.33%
Excl. one-offs YoY
-57.86%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+3.42%—
3 days+6.34%—
7 days+7.99%—
14 days-2.75%—

Report history

Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +4.92%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-30-¥6.80M-114.33%-57.86%+18.15%-0.02-0.76%+6.34%——
2026 interim report2026-08-18-¥32.87M-349.09%—+18.14%-0.08-3.71%+3.59%+9.23%+17.19%
2026 Q1 report2026-04-30¥27.19M+484.36%+311.18%+80.37%0.072.96%+16.90%+20.74%+18.69%
2025 annual report2026-03-31¥22.26M+7.24%-11.38%+19.58%0.052.38%+1.54%+31.47%+23.05%
2025 Q3 report2025-10-30¥47.48M+1079.36%+12157.47%+31.11%0.125.02%-2.12%+8.36%+13.11%
2025 interim report2025-08-29¥13.20M+147.22%+124.20%+35.17%0.031.42%-1.40%-21.76%-23.03%
2025 Q1 report2025-04-26-¥7.07M+72.79%+60.40%+23.58%-0.02-0.77%+2.57%+7.64%+4.39%
2024 annual report2025-03-29¥20.76M+18.24%+230.01%+18.69%0.052.24%+11.91%+5.26%+6.82%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688319

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.